Search results for " future" in Articles / App Notes

Article SEC in the Modern Downstream Purification Process
In the future, 3-D printing may give SEC yet another life. This emerging technology offers the ability to provide perfectly packed columns with precise bead and pore sizes. Because the pore size distr…

Article Technologies and Practices Must Evolve to Meet Demand
Survey participants also rated how the level of innovation in technology areas meets their current or future manufacturing needs. The majority of respondents rated most technologies as good, with some…

Article Securing the Single-Use Supply Chain
“Single-use products are not commodities and will not be in the foreseeable future; innovation is critical to improving the technology. While it also leads to the development of different designs and …

Article Continued Process Verification for Biopharma Manufacturing
…t of ongoing collaborative efforts facilitated by BPOG; results of that work may be published in the future. References 1. FDA, Guidance for Industry, Process Validation: General Principles a…

Article Single-Use and Continuous Processing Technologies Change Facility Design
Experts predict how the facilities of the future may look much different than most today. Facilities in use today and built during the past decade would easily be recognised by the original engine…

Article Applying GMPs to the BioPharma Supply Chain
There is an acknowledged gap between current capabilities of many suppliers and what will be needed in the future to support the industry in an increasingly demanding regulatory and end-user focused m…

Article Analyzing Proteins Using SEC, MALS, and UHPLC
…sitivity and advances in particle technology will further improve chromatographic performance in the future,” he notes. Some agrees that UHPLC-based SEC has begun emerging in the past few years a…

Article Bureaucratic Roadblocks Threaten Biopharma Growth
Upholding the system of intellectual property rights is essential to guaranteeing future innovation and future jobs not just for US biopharmaceutical companies, but also for other countries and other …

Article Monoclonal Antibodies Key to Unlocking the Biosimilars Market
…ab (Remsima/Inflectra) is an important milestone in the development of the biosimilar market and for future mAb approvals. The biosimilar was approved for the same range of autoimmune diseases as the…

Article Quality by Design—Bridging the Gap between Concept and Implementation
The future “desired state” would be an enabling regulatory strategy and a procedure that keeps pace with innovation with increased scientific dialogue between regulators and industry. It would even in…

Show All Results

Previous PageNext Page